Impact of multidisciplinary team working on the management of colorectal cancer

Chinese Medical Journal

Volumn 125, Issue 2, 2012, Pages 172-177

  Ye, Ying Jiang ^a   Shen, Zhan Long ^a   Sun, Xian Tao ^a   Wang, Zhi Feng ^a   Shen, Dan Hua ^a   Liu, Hui Jun ^a   Zhang, Wan Lei ^a   Chen, Ya Lin ^a   Zhou, Jing ^a   Poston, G J ^b   Wang, Shan ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Chemotherapy; Colorectal cancer; Computed tomography; Liver metastases; Multidisciplinary team; Overall survival; Surgery; TNM stages

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER THERAPY; COHORT ANALYSIS; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEALTH CARE PERSONNEL; HISTOPATHOLOGY; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIDISCIPLINARY TEAM; OVERALL SURVIVAL; PROGNOSIS; TEAMWORK;

AGED; COLORECTAL NEOPLASMS; DISEASE MANAGEMENT; FEMALE; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; MIDDLE AGED; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 84862956477     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.02.002     Document Type: Article

References (25)

1. Association of Breast Surgery @ BASO, Royal College of Surgeons of England. Guidelines for the management of symptomatic breast disease. Eur J Surg Oncol 2005; 31: S1-S21.
2. Stephens MR, Lewis WG, Brewster AE, Lord I, Blackshaw GR, Hodzovic I, et al. Multidisciplinary team management is associated with improved outcomesafter surgery for esophageal cancer. Dis Esophagus 2006; 19: 164-171.
3. Davies AR, Deans DA, Penman I, Plevris JN, Fletcher J, Wall L, et al. The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer. Dis Esophagus 2006; 19: 496-503.
4. Junor EJ, Hole DJ, Gillis CR. Management of ovarian cancer: referral to a multidisciplinary team matters. British J Cancer 1994; 70: 363-370.
5. McArdle CS, McKee RF, Finlay IG, Wotherspoon H, Hole DJ. Improvement insurvival following surgery for colorectal cancer. Br J Surg 2005; 92: 1008-1013.
6. Haward RA. Using service guidance to shape the delivery of cancer services: experience in the UK. Br J Cancer 2003; 89: S12-S14.
7. Figuerdo A, Coombes ME, Mukherjee S. Adjvuant therapy for completely resected stage II colon cancer. Cochrane Database of Systematic Reviews 2008; CD005390.
8. Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clinl Oncol 2004; 15: 3408-3419.
9. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003; 21: 2912-2919.
10. Greene F, Page D, Fleming I, eds. Colon and Rectum. In: The AJCC Cancer Staging Handbook, Sixth Edition. New York: Springer; 2002: 127-138.
11. Mayes GB, Zomoza J. Computed tomography of colon carcinoma. Am J Roentgenol 1980; 135: 43-46.
12. Thoeni RF, Moss AA, Schnyder P, Margulis AR. Detection and staging of primary rectal and rectosigmoid cancer by computed tomography. Radiology 1981; 141: 135-138.
13. Fisher JK. Abnormal comic wall thickening on computed tomography. J Comput Assist Tomogr 1983; 7: 90-97.
14. Dixon AK, Fry IK, Morson BC, Nicholls RJ, Mason AY. Preoperative computed tomography of carcinoma of the rectum. Br J Radiol 1981; 54: 655-659.
15. Grabbe E, Lierse W, Winkler R. The penrectal fascia: morphology and use in staging of rectal carcinoma. Radiology 1983; 149: 241-246.
16. Freeny PC, Marks WM, Ryan JA, Bolen JW. Colorectal carcinoma evaluation with CT: preoperative staging and detection of postoperative recurrence. Radiology 1986; 158: 347-353.
17. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
18. Jaffe BM, Donegan WL, Watson F, Spratt JS Jr. Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 1968; 127: 1-11.
19. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional vs systemic continuous 5-FU chemotherapy in the treatment of colorectal metastases. Ann Surg 1987; 206: 685-693.
20. Cunningham D, Pyrhönen S, James RD, Punt CJ, Hickish TF, Heikkila R. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998; 352: 1413-1418.
21. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of the published studies. Br J Cancer 2006; 94: 982-999.
22. Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 2006; 13: 668-676.
23. Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999; 10: 663-669.
24. Heriot AG, Reynolds J, Marks CG, Karanjia N. Hepatic resection for colorectal metastases e a national perspective. Ann R Coll Surg Engl 2004; 86: 420-424.
25. Bismuth H, Adam R, Lévi F, Farabos C, Waechter F, Castaing D. Resection of non resectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224: 509-520.